skip to content
skip to content
skip to content

Our partners 


Research plays a vital role throughout St Vincent's and the organisation supports many innovative projects and clinical trials.


The extent of research undertaken at St Vincent's displays the outstanding commitment and achievements of individuals and research teams. Research at the Fitzroy campus is conducted in collaboration with hospital departments and our greater cross-campus partners.





University of Melbourne, a member of the GO8, is one of the foremost Australian research universities and an international leader.

The University has an important and unique role in overseeing and training students at Honours, Masters and Doctoral level involved in research on the campus.

The University has a very strong presence at St Vincent’s with thriving Departments of Surgery, Medicine, a unit of the Department of Psychiatry and a Clinical School forming the St Vincent’s Academic Centre of the Melbourne Medical School. The Melbourne School of Health Sciences and Melbourne School of Population Health also have a presence in teaching and research at St Vincent’s.



St Vincent’s Institute (SVI) is recognised nationally and internationally as being one of the best medical research institutes in Australia, and is home to three Fellows of the Australian Academy of Science.

SVI research focuses on several of the most common causes of illness and death in Australian society: cancer, high blood pressure, heart disease, type 1 and 2 diabetes, obesity, arthritis and osteoporosis.

SVI is expert at laboratory-based research, particularly in applying leading-edge technology to the study of protein structure and function. This technology remains at the heart of SVI’s activities and competitive advantage. Researchers at SVI have solved the structure of over 50 proteins; the most recent of these is a signalling receptor involved in a variety of diseases, including arthritis and leukaemia.




The O’Brien Institute (OBI) is dedicated to tissue engineering, organogenesis and regenerative surgery.

Having established platform technologies such as Australia’s first Stem Cell bank ‘Cyentia’, the OBI team works with many other scientists and researchers across the country.

The team assists in the development of new drugs, stem cell research and the discovery and development of new organ regeneration therapies. This team is now embarking on the Victorian Government STI grant supported ‘NeoPec’ trial, regenerating breast tissue for women who have undergone mastectomies and also continues to provide trauma patients with leading edge microsurgery.



The Bionics Institute has an international reputation for scientific rigor and research excellence. Institute founder Professor Graeme Clark and his team developed the first multi-channel Bionic Ear (cochlear implant) in 1978.

Today more than 180,000 cochlear implant operations have been performed around the world, providing hearing and the ability to understand spoken language, thanks to the Bionic Ear.

The Bionics Institute now aims to create bionic technologies to treat ailments in many areas of the human body, including a Bionic Eye, High Fidelity Bionic Ear, brain implants for the treatment of Epilepsy and Therapeutic Drug Delivery.



Australian Catholic University (ACU) has a strong commitment to providing educational excellence and support to researchers, students and staff of all beliefs.

ACU supports collaborative research via the National Centre for Clinical Outcomes Research which includes The Centre for Nursing Research at St Vincent’s.

A further initiative is the Cardiovascular Research Centre at St Vincent’s, an initiative between the hospital, ACU and the University of Melbourne.






41 Victoria Parade, Fitzroy VIC 3065, Australia. Phone: (03) 9288 2211